Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection
Media-OutReach Newswire HKU’s innovative research novelties excel at 48th International Exhibition of Inventions of Geneva
Media-OutReach Newswire Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth
Media-OutReach Newswire Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Media-OutReach Newswire YS Biopharma Received Qualified Person Declaration for Its PIKA COVID-19 Vaccine Facility from European Union GMP